Male Infertility Market Size Hit $6.21Bn, Globally, by 2027 Growing at 6.2% CAGR | Exclusive Report by The Insight Partners
August 03, 2022 10:54 ET
|
The Insight Partners
New York, Aug. 03, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Male Infertility Market Global Analysis and Forecast – by Test, Treatment Type, Distribution...
Outlook on the Fertility Services Global Market to 2027 - by Procedure, Patients, End-user and Region
June 16, 2022 06:48 ET
|
Research and Markets
Dublin, June 16, 2022 (GLOBE NEWSWIRE) -- The "Global Fertility Services Market (2022 Edition) - Analysis By Procedure, Patients, End User, By Region, By Country (2022 Edition): Market Insights, and...
The Worldwide Vitrification Industry is Expected to Reach $22.4 Billion by 2028
April 25, 2022 04:48 ET
|
Research and Markets
Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "Vitrification Market Share, Size, Trends, Industry Analysis Report, By Specimen, By End-Use, By Region; Segment Forecast, 2021 - 2028" report has been...
Insights on the Infertility Testing and Treatment Global Market to 2028 - Growth in Stress and Lifestyle Disorders is Driving the Industry
July 28, 2021 06:23 ET
|
Research and Markets
Dublin, July 28, 2021 (GLOBE NEWSWIRE) -- The "Global Infertility Testing and Treatment Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. As per this research report, the...
India In-vitro Fertilization Market Report 2020: Historical Data 2015-2016, Base year of 2020, Estimates for 2021 & Forecasts 2022-2026
November 23, 2020 03:53 ET
|
Research and Markets
Dublin, Nov. 23, 2020 (GLOBE NEWSWIRE) -- The "India In-vitro Fertilization Market By Technique (ICSI IVF v/s Non-ICSI/ Traditional IVF), By Product (IVF Culture Media, ICSI Machine, IVF Incubators,...
Callitas Health, Inc Receives Notice of Allowance from USPTO for Patent Application for Treatment for Male Infertility and Sub-Fertility
March 08, 2018 18:17 ET
|
Callitas Health Inc.
CINCINNATI, OH , March 08, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...